Mallinckrodt Initiates Retrospective Study of the Use of Inhaled Nitric Oxide in COVID-19 Patients
Mallinckrodt plc, a global biopharmaceutical company, announced initiation of a retrospective chart review study, titled “Nitric Oxide Treatment In COVID-19 Evaluation (NOTICE)” to collect...
NHS Digital deals to improve data sharing between organizations.
NHS Digital, the national provider of information, data, IT systems for clinicians in health and social care in England is on the path of...
Are Indian Pharmaceutical Companies Up For The Chinese Challenge?
For long Asian Countries, specifically China and India has been known to supply the world with pharmaceuticals at a very reasonable price. With that...
The Falling Graph of Dose Contract Manufacturing
One could witness slow revenue growth of Dose Contract Manufacturing Organizations in 2019. Expectations were high on its revival in 2020, but unfortunately, things...
A Democrat Senate & its implications on The Pharmaceutical Sector ?
The US elections make big news whenever they occur. The fact that who comes to power has a phenomenal effect on all industries, big...
Cancer Treatment Can Be Cloned For COVID-19
As per the recent international study by the scientists from Italy & Australia, Beta-blockers have it in them to be a potential treatment for...
Vetter continues its long-term investment strategy to sustain future growth
Vetter, a globally leading contract development and manufacturing organization (CDMO), has moved into its new headquarters in Ravensburg, Germany. The opening of the new...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...